Leukemia Cells Current Events | Leukemia Cells News | 11
|
| Page
11 of
23 |
454 Results |
|
|
|
Sort By:
Page Views | Date |
Researchers first to map gene that regulates adult stem cell growth
A new discovery in stem cell research may mean big things for cancer patients in the future. Gary Van Zant, Ph.D., and a research team at the University of Kentucky published their findings today in Nature Genetics, an international scientific journal. view more (2007-01-15)
Hodgkin lymphoma -- new characteristics discovered
Researchers are still discovering new characteristics of Hodgkin lymphoma, a common form of cancer of the lymphatic system. The malignant cells are derived from white blood cells (B cells), but have lost a considerable part of the B cell-specific gene expression pattern. view more (2008-10-09)
Inventory of Genes
Scientists at DKFZ screen fruit fly genome for cancer-relevant genes Dr. Michael Boutros of the Deutsches Krebsforschungszentrum (German Cancer Research Center, DKFZ) and an international team of collaborators have been the first to screen an almost complete genome for genes that could play a role in cancer. The results have been published in the... view more... (2004-02-09)
Breast cancer drug shows promise against serious infections
An FDA-approved drug used for preventing recurrence of breast cancer shows promise in fighting life-threatening fungal infections common in immune-compromised patients, such as infants born prematurely and patients with cancer. view more (2009-07-21)
A new weapon in the war against HIV-AIDS: Combined antiviral and targeted chemotherapy
A discovery by a team of Canadian and American researchers could provide new ways to fight HIV-AIDS. According to a new study published in Nature Medicine, HIV-AIDS could be treated through a combination of targeted chemotherapy and current Highly Active Retroviral (HAART) treatments. view more (2009-06-22)
Cancer drug may be remedy for rheumatoid arthritis, Stanford study finds
The potent cancer drug Gleevec, used to combat leukemia and some gastrointestinal cancers, may be useful in treating rheumatoid arthritis. view more (2006-09-29)
Scientists use gene signatures to match cancer and other diseases with potentially effective drugs
In one of the most ambitious spinoffs of the human genome project, researchers at Dana-Farber Cancer Institute, Children's Hospital Boston, the Broad Institute of Harvard and MIT, and other collaborating centers have unveiled a new, systematic approach to drug discovery that matches diseases with potential treatments using a universal language... view more... (2006-09-29)
Children's national co-leads nationwide study of landmark sickle cell treatment
Children's National Medical Center immunologist and blood and marrow transplant physician Naynesh Kamani, MD, will serve as the study co-chair for a new national clinical trial of unrelated donor marrow and umbilical cord blood transplants for severe sickle cell disease. view more (2008-08-19)
Crucial Factors in Lymphoma Development and Survival Discovered
Researchers at National Jewish Medical and Research Center have discovered an important factor in the development of B-cell lymphomas, one of the fastest growing forms of cancer. view more (2008-06-24)
Childhood leukemia survivors struggle with long-term comorbidities
Survival rates of childhood cancers, especially leukemia, have improved greatly in the past three decades, but survivors of this disease still seem to face many health and lifestyle challenges as young adults. view more (2008-04-01)
UCLA cancer researchers develop model that may help identify cancer stem cells
Researchers at UCLA's Jonsson Comprehensive Cancer Center, on a quest to find lung cancer stem cells, have developed a unique model to allow further investigation into the cells that many believe may be at the root of all lung cancers. view more (2009-06-16)
Drug Offers New Options for Leukemia Patients
Dasatinib, an experimental drug under development by Bristol-Myers Squibb, reverses the signs and symptoms of patients whose chronic myeloid leukemia has failed to respond to Gleevec, which is considered the standard of treatment for the disorder. view more (2006-06-15)
Investigational cancer drug targets critical proteins
A drug under study to treat various cancers selectively kills cancer cells because of its affinity for a modified version of a critical heat shock protein they contain, researchers have found. view more (2007-04-16)
The 2001 Jeanne Loubaresse - Institut Curie European Prize : Pr Peter E. Nielsen awarded for his works on PNAs, chimera molecules analogues to DNA
The 2001 Jeanne Loubaresse - Institut Curie european prize was delivered the 25th of June 2002 by Pr Claude Héle'ne during a ceremony taking place at the Institut Curie. Worth 60 000 euros, it awards Peter E. Nielsen, professor at the Panum Institute (University of Copenhagen, Denmark), "inventor" of PNAs (Polyamide Nucleic Acids), chimera... view more... (2002-07-02)
U-M researchers discover new genes that fuse in cancer
Using new technologies that make it easier to sequence the human genome, researchers at the University of Michigan Comprehensive Cancer Center have identified a series of genes that become fused when their chromosomes trade places with each other. view more (2009-01-12)
New studies identify advances in treatment of chronic myeloid leukemia
Offering promise in the battle against cancer, the results from five studies highlighting new advances in the treatment of chronic myeloid leukemia (CML) - a slow-progressing, malignant bone marrow cancer - will be presented at the 47th Annual Meeting of the American Society of Hematology. view more (2005-12-12)
Cellular discovery may lead to targeted treatment for rare form of anemia
University of Cincinnati (UC) researchers have identified the specific biological mechanisms believed to lead to a rare and incurable blood disease known as Diamond Blackfan anemia (DBA). Scientists say with further investigation, their discoveries could result in drastic changes to current thinking about treatment for this disease and may lead to... view more... (2009-03-16)
Drug slows prostate tumor growth by keeping vitamin A active
A novel compound that blocks the breakdown of retinoic acid, derived from vitamin A, is a surprisingly effective and "promiscuous" agent in treating animal models of human prostate cancer, say investigators from the University of Maryland, Baltimore (UMB). view more (2007-11-07)
Novel therapy may prove effective in treatment of 30 percent of cancers
A ground-breaking Canada-wide clinical trial led by Dr. Katherine Borden, at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal, has shown that a common anti-viral drug, ribavirin, can be beneficial in the treatment of cancer patients. view more (2009-05-14)
Molecular 'GPS' helps researchers probe processes important in aging and disease
With all the hype about beneficial antioxidants in everything from face cream to cereal bars, you'd think their targets-oxygen radicals-must be up to no good. view more (2009-09-04)
|
|
| Page
11 of
23 |
454 Results |
|
|
|
Sort By:
Page Views | Date |
|
